Internal Medicine, Hematology & Oncology · Springfield, MO
NPI
1720056823
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3850 S National Ave, Suite 600
Springfield, MO, 65807
Phone (417) 882-4880
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
171,321 services
Medicare patients, 2024
597
Average age 74
Drug cost, 2024
$8.1M
2,847 prescriptions
Company payments, 2025
$933
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Ellis was code J9271 (injection, pembrolizumab, 1 mg), 20,500 times for 15 patients. In total Robert J Ellis billed 171,321 services in 148 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 20,500 | 15 | $44.70 | $916K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 17,460 | 13 | $39.27 | $686K |
| J0185 Injection, aprepitant, 1 mg | Office | 8,970 | 23 | $1.34 | $12K |
| J0897 Injection, denosumab, 1 mg | Office | 3,180 | 20 | $20.58 | $65K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,556 | 53 | $0.09 | $229 |
| 85025 Blood Count | Office | 1,661 | 445 | $7.59 | $13K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,450 | 35 | $0.69 | $1,007 |
| 36415 Venipuncture Blood Collection | Office | 1,345 | 420 | $8.61 | $12K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 780 | 21 | $0.07 | $56.95 |
| 99213 Office E&M - Established | Office | 774 | 351 | $60.43 | $47K |
| 80053 Clinical Chemistry | Office | 742 | 224 | $10.35 | $7,680 |
| 99214 Office E&M - Established | Office | 725 | 267 | $89.13 | $65K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 546 | 77 | $69.19 | $38K |
| 96375 Injection Administration | Office | 527 | 59 | $10.34 | $5,450 |
| 96413 Chemotherapy Administration | Office | 416 | 76 | $84.91 | $35K |
By year: 2022 $3.6M for 181,106 services; 2023 $4.1M for 162,640 services; 2024 $4.9M for 171,321 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,661 | 445 | $7.59 | $13K |
| 36415 Venipuncture Blood Collection | 1,345 | 420 | $8.61 | $12K |
| 80053 Clinical Chemistry | 742 | 224 | $10.35 | $7,680 |
| 81002 Clinical Chemistry | 79 | 26 | $3.30 | $261 |
| 85045 Blood Count | 13 | 13 | $3.91 | $50.83 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Ellis prescribed most often to Medicare patients was Anastrozole, with 182 prescriptions and refills. In total Robert J Ellis wrote 2,847 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 182 | 400 | 52 | $2,631 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 124 | 124 | 41 | $2,985 |
| Hydroxyurea Generic | 114 | 224 | 25 | $2,954 |
| Eliquis Apixaban | 108 | 150 | 23 | $89K |
| Gabapentin Generic | 106 | 118 | 23 | $688 |
| Acyclovir Generic | 104 | 134 | 25 | $2,354 |
| Letrozole Generic | 84 | 163 | 24 | $1,273 |
| Ondansetron Hcl Generic | 83 | 84 | 30 | $7,108 |
| Oxycodone Hcl Generic | 71 | 71 | 22 | $1,659 |
| Pomalyst Pomalidomide | 71 | 71 | 14 | $1.6M |
| Alprazolam Generic | 64 | 64 | 14 | $232 |
| Imbruvica Ibrutinib | 61 | 61 | Under 11 | $906K |
| Morphine Sulfate Er Morphine Sulfate | 59 | 59 | 13 | $1,793 |
| Dexamethasone Generic | 57 | 74 | 30 | $1,027 |
| Prednisone Generic | 52 | 70 | 29 | $220 |
Brand drugs: 682 claims; generic drugs: 2,165 claims; opioid claims: 358.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Ellis $933 ($933 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $285.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $285 |
| Aveo Pharmaceuticals, Inc. | 3 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Tempus AI, Inc TEM | 1 | $61.16 |
| Celgene Corporation BMY | 3 | $50.17 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $40.4 |
| Medinc of Texas | 1 | $33.53 |
| Stemline Therapeutics Inc. | 1 | $30.93 |
| Abbvie Inc. ABBV | 1 | $30.27 |
| Daiichi Sankyo Inc. 4568.T | 1 | $26.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.